US2003190632A1PendingUtilityA1

Method for enhancing the hybridization efficiency of target nucleic acids using a self-addressable, self-assembling microelectronic device

Assignee: NANOGEN INCPriority: Nov 1, 1993Filed: Jun 11, 2002Published: Oct 9, 2003
Est. expiryNov 1, 2013(expired)· nominal 20-yr term from priority
H10W 72/0198H10W 90/00B01J 19/0046H10D 64/021H10D 30/0275H10D 30/0227H10D 30/608C12Q 1/6837B01J 19/0093C07H 21/00B01L 3/50273C12Q 1/6825G11C 19/00G11C 13/04B01J 2219/00722B01L 3/5085C07K 1/047G11C 13/0014C07K 1/045B01J 2219/00637B01L 2300/0645B01L 2200/0647C40B 60/14B01J 2219/00527B01J 2219/00596B01J 2219/00626B01L 2200/10B01J 2219/00315B01J 2219/0063B01J 2219/00644B01J 2219/00612B01L 3/502761C40B 40/06B01L 3/502707B01J 2219/00713C07B 2200/11B01J 2219/0072B01J 2219/0061B01J 2219/00686C40B 40/12B01J 2219/00725G11C 13/0019B01J 2219/00659B01J 2219/00585B01J 2219/00635B01L 2400/0421B01J 2219/0059B01J 2219/00731B01J 2219/00621C12Q 1/6832C07K 1/04C40B 40/10B01L 2400/0415B01J 2219/00605B01J 2219/00653B01L 2300/0636B01J 2219/00317B01J 2219/00689B82Y 5/00B82Y 10/00C12Q 1/6827
41
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A self-addressable, self-assembling microelectronic device is designed and fabricated to actively carry out and control multi-step and multiplex molecular biological reactions in microscopic formats. These reactions include nucleic acid hybridizations, antibody/antigen reactions, diagnostics, and biopolymer synthesis. The device can be fabricated using both microlithographic and micro-machining techniques. The device can electronically control the transport and attachment of specific binding entities to specific microlocations. The specific binding entities include molecular biological molecules such as nucleic acids and polypeptides. The device can subsequently control the transport and reaction of analytes or reactants at the addressed specific microlocations. The device is able to concentrate analytes and reactants, remove non-specifically bound molecules, provide stringency control for DNA hybridization reactions, and improve the detection of analytes. The device can be electronically replicated.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for transport and hybridization of DNA in an active electronic system comprising the steps of: 
 providing a low conductivity, zwitterionic buffer on said device,    electrophoretically transporting said nucleic acid towards a microlocation,    applying current and voltage to the microlocation to effect transportation, whereby the local pH above the microlocation is below the pH of the buffer at its isoelectric point, whereby hybridization between the nucleic acid and a probe located at the microlocation is enhanced.    
     
     
         2 . The method for enhanced transport and hybridization of nucleic acids of  claim 1 , wherein the low conductivity, zwitterionic buffer is histidine.  
     
     
         3 . The method for enhanced transport and hybridization of nucleic acids of  claim 1 , wherein the low conductivity, zwitterionic buffer is L-histidine.  
     
     
         4 . The method for enhanced transport and hybridization of nucleic acids of  claim 1 , wherein the low conductivity, zwitterionic buffer is D-histidine.  
     
     
         5 . A method for the effective transport and hybridization of DNA on an active, electronic matrix device, the device having a plurality of microlocations, at least certain of the microlocations including probes, comprising the steps of: 
 providing a first low-conductivity, zwitterionic buffer to the device,    providing said nucleic acids to the device in said low conductivity, zwitterionic buffer,    applying current and potential to at least certain microlocations so as to effect transport of said nucleic acids to selected microlocations,    changing the buffer to a second buffer with a high salt concentration, and    effecting hybridization of said nucleic acid with said probe at selected microlocations.    
     
     
         6 . The method for effecting transport and hybridization of nucleic acids of  claim 5 , wherein the low conductivity, zwitterionic buffer is cystine.  
     
     
         7 . The method for effecting transport and hybridization of nucleic acids of  claim 5 , wherein the low conductivity, zwitterionic buffer is alanine.  
     
     
         8 . The method for effecting transport and hybridization of nucleic acids of  claim 5 , wherein the salt concentration is from approximately 50 mM to 100 mM.  
     
     
         9 . A method for detection of point mutations in double stranded amplicons comprising the steps of: 
 providing amplicon products to an active, programmable electronic matrix device,    dilute said products in a low conductance histidine buffer, denature said products,    hybridize said denatured products in the histidine buffer on the device,    perform stringency so as to discriminate matches versus mismatches, and    detect and analyze said products.    
     
     
         10 . The method of  claim 9  for detecting point mutations in amplicons wherein the stringency includes electronic stringency.  
     
     
         11 . The method of  claim 9  for detecting point mutations in amplicons wherein the detection is fluorescent detection.  
     
     
         12 . The method of  claim 9  for detecting point mutations in amplicons wherein a fluorescent reporter probe sequence is hybridized with said product.

Join the waitlist — get patent alerts

Track US2003190632A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.